Treatment for polycystic ovarian syndrome (pcos)
AssigneeCadila Healthcare Limited
InventorsMukul Jain, Deven V. Parmar, Amit Joharapurkar
Life of this patent
Estimating the term…
Abstract
Present invention provides the method of treating polycystic ovarian syndrome using compound of formula (I) or pharmaceutically acceptable salt thereof, preferably it provides method of treating polycystic ovarian syndrome in the patient diagnosed with NAFLD. Invention also provides a pharmaceutical composition comprising compound of formula (I) for treatment of polycystic ovarian syndrome, wherein compound of formula (I) is
Claims50
A pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof selected from Na+, K+, Ca+2, and Mg+2, for use in the treatment of polycystic ovarian syndrome (PCOS) in a patient in need of such treatment, wherein formula (I) is represented by
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of treating polycystic ovarian syndrome (PCOS) in a subject in need thereof, the method comprising administering to the subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof selected from Na+, K+, Ca+2, and Mg+2, or a pharmaceutical formulation thereof, wherein formula (I) is represented by
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of treating polycystic ovarian syndrome (PCOS) in a subject diagnosed with NAFLD, the method comprising administering to the subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof selected from Na+, K+, Ca+2, and Mg+2, or a pharmaceutical formulation thereof, wherein formula (I) is represented by
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.